Treace Medical Concepts, Inc. (TMCI)
1.93
+0.08
(+4.32%)
USD |
NASDAQ |
Feb 19, 15:49
Treace Medical Concepts EPS Diluted (Quarterly) : -0.2564 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.29M |
| Revenue (Quarterly) | 50.21M |
| Total Expenses (Quarterly) | 66.50M |
| Enterprise Value | 130.83M |
| Gross Profit Margin (Quarterly) | 79.07% |
| Profit Margin (Quarterly) | -32.44% |
| Earnings Yield | -41.17% |
| Normalized Earnings Yield | -41.15 |